5% STAKE4883.TTSECAYMAN ISLANDS

Evo Fund lowers stake in Modalis Therapeutics to 11.95%

Stake history

10%12%14%16%18%15.95%PriorPrior: 15.95% · prior ratio stated in S100U2AC11.95%Jul 19Jul 19: 11.95% · S100U2AC
10%12%14%16%18%15.95%PriorPrior: 15.95% · prior ratio stated in S100U2AC11.95%Jul 19Jul 19: 11.95% · S100U2AC

Summary

Evo Fund and joint holders filed a Change in 5%+ stake (change report) via EDINET on 2024-07-19 11:51 JST concerning Modalis Therapeutics Corporation. Reported holding ratio: 11.95%, previous report: 15.95%.

Open the price chart on TradingView.

Source: EDINET S100U2AC ↗ · PDL1.0 · Not investment advice